Braze, Inc. (NASDAQ:BRZE) is one of the Best 52-Week Low Stocks to Buy According to Analysts. On June 24, Oppenheimer lowered ...

Fintel reports that on July 16, 2025, Oppenheimer initiated coverage of MBX Biosciences (NasdaqGS:MBX) with a Outperform recommendation. Analyst Price Forecast Suggests 207.65% Upside As of June 20, ...

Abbott Laboratories remains a top pick in volatile markets thanks to strong fundamentals and regulatory tailwinds.

Oppenheimer analyst Brian Schwartz issued a bullish outlook for Microsoft (NASDAQ: MSFT), raising its price target to $600—a ...

Fintel reports that on July 9, 2025, Oppenheimer upgraded their outlook for BridgeBio Pharma (NasdaqGS:BBIO) from Perform to ...

Detailed price information for Sei Investments Company (SEIC-Q) from The Globe and Mail including charting and trades.

CME Group is growing new products, markets, and users, as well as having achieved profit margins beating its sector and key ...

Barclays analyst Benjamin Budish maintained a Hold rating on CME Group today and set a price target of $283.00. The company’s shares closed yesterday at $275.82. Don’t Miss Ti ...

TLDR XRP price broke above a descending channel at $2.20 with analyst targeting $2.40 as the next key level The token needs to break another descending channel at $2.2962 to reach the $2.40 target XRP ...

Nvidia remains the dominant AI chipmaker in the market, but where is the stock headed for the rest of this year and into the next?